Breaking News

Tuesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
BEST

Best Inc

$5.89

-0.08 (-1.34%)

, AHL

Aspen Insurance

$42.74

(0.00%)

08:30
02/19/19
02/19
08:30
02/19/19
08:30
Options
One new option listing and twelve option delistings on February 19th »

New option listings for…

BEST

Best Inc

$5.89

-0.08 (-1.34%)

AHL

Aspen Insurance

$42.74

(0.00%)

BSTI

Best Inc.

$5.89

-0.08 (-1.34%)

EMMS

Emmis Communications

$3.75

(0.00%)

HECO

Hallwood Energy

$40.54

(0.00%)

ISSC

Innovative Solutions

$2.70

0.05 (1.89%)

LOXO

Loxo Oncology

$234.66

(0.00%)

MB

Acquired by Vista Equity Partners

$36.46

(0.00%)

MBIN

Merchants Bancorp

$21.45

1.39 (6.93%)

MBTF

MBT Financial

$11.04

0.29 (2.70%)

SEED

Origin Agritech

$6.79

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a week ago
LLY

Eli Lilly

$120.69

1.615 (1.36%)

, LOXO

Loxo Oncology

$234.66

-0.04 (-0.02%)

09:26
02/15/19
02/15
09:26
02/15/19
09:26
Hot Stocks
Eli Lilly reaffirms FY19 guidance »

Lilly (LLY) has…

LLY

Eli Lilly

$120.69

1.615 (1.36%)

LOXO

Loxo Oncology

$234.66

-0.04 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

LLY

Eli Lilly

$121.04

0.89 (0.74%)

, TEVA

Teva

$20.11

0.425 (2.16%)

14:58
02/05/19
02/05
14:58
02/05/19
14:58
Earnings
On The Fly: What to watch in Eli Lilly earnings report »

Eli Lilly (LLY) is…

LLY

Eli Lilly

$121.04

0.89 (0.74%)

TEVA

Teva

$20.11

0.425 (2.16%)

LOXO

Loxo Oncology

$234.59

0.19 (0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

  • 13

    Feb

  • 18

    May

LOXO

Loxo Oncology

$234.52

0.63 (0.27%)

, LLY

Eli Lilly

$119.81

2.84 (2.43%)

06:52
02/01/19
02/01
06:52
02/01/19
06:52
Hot Stocks
Eli Lilly's acquisition of Loxo Oncology reaches HSR waiting period expiration »

Eli Lilly (LLY)…

LOXO

Loxo Oncology

$234.52

0.63 (0.27%)

LLY

Eli Lilly

$119.81

2.84 (2.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

  • 18

    May

LLY

Eli Lilly

$119.81

2.84 (2.43%)

, LOXO

Loxo Oncology

$234.52

0.63 (0.27%)

06:51
02/01/19
02/01
06:51
02/01/19
06:51
Hot Stocks
Eli Lilly announces expiration of HSR waiting period to acquire Loxo Oncology »

Eli Lilly (LLY) and Loxo…

LLY

Eli Lilly

$119.81

2.84 (2.43%)

LOXO

Loxo Oncology

$234.52

0.63 (0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

  • 18

    May

INCY

Incyte

$77.45

2.25 (2.99%)

, NVS

Novartis

$86.82

-1.34 (-1.52%)

11:14
01/24/19
01/24
11:14
01/24/19
11:14
On The Fly
Incyte rises as analyst says buy on takeout potential, ‘resurgent’ pipeline »

Shares of Incyte (INCY)…

INCY

Incyte

$77.45

2.25 (2.99%)

NVS

Novartis

$86.82

-1.34 (-1.52%)

LLY

Eli Lilly

$117.23

-1.58 (-1.33%)

BMY

Bristol-Myers

$50.00

0.08 (0.16%)

CELG

Celgene

$86.96

0.46 (0.53%)

LOXO

Loxo Oncology

$233.66

0.01 (0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 28

    Jan

  • 06

    Feb

  • 14

    Feb

  • 28

    Feb

  • 18

    May

  • 20

    May

  • 24

    May

  • 28

    May

Over a month ago
LOXO

Loxo Oncology

$233.24

-0.19 (-0.08%)

, LLY

Eli Lilly

$119.20

2.46 (2.11%)

04:56
01/18/19
01/18
04:56
01/18/19
04:56
Downgrade
Loxo Oncology, Eli Lilly rating change at William Blair »

Loxo Oncology downgraded…

LOXO

Loxo Oncology

$233.24

-0.19 (-0.08%)

LLY

Eli Lilly

$119.20

2.46 (2.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

  • 18

    May

LLY

Eli Lilly

$115.67

-0.32 (-0.28%)

, LOXO

Loxo Oncology

$232.56

0.055 (0.02%)

15:32
01/11/19
01/11
15:32
01/11/19
15:32
Periodicals
Lilly CEO says will leave CAR-T therapies to others, Reuters says »

Eli Lilly (LLY) CEO Dave…

LLY

Eli Lilly

$115.67

-0.32 (-0.28%)

LOXO

Loxo Oncology

$232.56

0.055 (0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jan

  • 28

    Jan

  • 18

    May

LOXO

Loxo Oncology

$232.72

92.9 (66.44%)

, LLY

Eli Lilly

$115.25

0.6 (0.52%)

07:43
01/08/19
01/08
07:43
01/08/19
07:43
Downgrade
Loxo Oncology, Eli Lilly, Mirati Therapeutics rating change at Citi »

Loxo Oncology downgraded…

LOXO

Loxo Oncology

$232.72

92.9 (66.44%)

LLY

Eli Lilly

$115.25

0.6 (0.52%)

MRTX

Mirati Therapeutics

$48.29

3.35 (7.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

  • 14

    Jan

  • 28

    Jan

  • 18

    May

LLY

Eli Lilly

$115.25

0.6 (0.52%)

, LOXO

Loxo Oncology

$232.72

92.9 (66.44%)

06:54
01/08/19
01/08
06:54
01/08/19
06:54
Periodicals
U.S. drugmakers eye M&A following cancer-drug deals, Bloomberg reports »

Following Eli…

LLY

Eli Lilly

$115.25

0.6 (0.52%)

LOXO

Loxo Oncology

$232.72

92.9 (66.44%)

BMY

Bristol-Myers

$48.42

1.54 (3.29%)

CELG

Celgene

$87.44

2.52 (2.97%)

GILD

Gilead

$68.54

0.27 (0.40%)

PFE

Pfizer

$43.23

0.24 (0.56%)

MRK

Merck

$75.46

-0.8 (-1.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

  • 11

    Jan

  • 14

    Jan

  • 24

    Jan

  • 28

    Jan

  • 29

    Jan

  • 16

    Feb

  • 11

    Apr

  • 18

    May

  • 20

    May

  • 28

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.